First-in-class therapy repairs DNA damage in Alzheimer's model Written byBree Foster, PhD

First-in-class therapy repairs DNA damage in Alzheimer's model KCL-286 repaired neuronal DNA damage and reduced neuroinflammation in mice, with prior Phase 1 safety data potentially accelerating its path to Alzheimer's trials. Written byBree Foster, PhD https://www.drugdiscoverynews.com/first-in-class-therapy-repairs-dna-damage-in-alzheimer-s-model-17317